Keck School of Medicine of USC
M

Acute Kidney Injury in Patients with Cirrhosis (2024)

By Keck School of Medicine of USC FEATURING Mitra Nadim
By Keck School of Medicine of USC FEATURING Mitra Nadim
26 views
September 25, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:46
Houston Methodist

MAFLD: What Is It?

Feat. D. Victor
32:17
University of Miami

New Treatments for Steatotic Liver Disease (SLD): Are We There Yet?

Feat. S. A. Harrison
19:33
ARCH Advanced Revascularization Symposium

Contrast Nephropathy

29:45
Houston Methodist DeBakey Heart and Vascular Center

Heart and Liver Interactions

Feat. S. Adeel Ahsan
43:23
MedNews Week

Best Practices In Managing NAFLD / NASH

Feat. D. Bernstein
44:20
UCSF School of Medicine

Alcohol Use Disorder

Feat. T. Defries
25:25
Icahn School of Medicine at Mount Sinai

NASH Update 2023

Feat. M. B. Bansal
34:32
Ronald Goldenberg

Important Safety Information - Off-Target Effects of New Therapies f…

38:47
UPMC

The Fatty Liver Disease Epidemic

Feat. M. Klinge
31:02
Scripps Health

Pharmacologic Management of Alcohol Use Disorder

Feat. R. Lee
49:14
Scripps Health

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Feat. J. Gutierrez
60:44
Scripps Health

Rising Burden of Alcohol Use Disorder: Management and Outcomes

Feat. J. Gutierrez
58:35
University of Colorado Department of Medicine

Updates in Nephrology

Feat. A. Jovanovich
23:42
UCLA Health

Update on Hepatology Literature

Feat. J. Benhammou, C. Wong
21:14
Cardiometabolic Health Congress (CMHC)

The Evolving Landscape of Non-Alcoholic Fatty Liver Disease (NAFLD) …

Feat. K. Cusi
19:45
Houston Methodist

Alcoholism is a Mid-brain Disease: Treat it as Such

Feat. H. Wetsman
48:59
Northwestern Medicine Gastroenterology

Cutting Edge Diagnostics and Treatment for NAFLD

Feat. M. E. Rinella, L. Van Wagner
27:35
Yale School of Medicine

Fatty Liver Disease: When to Refer?

37:57
Duke Health

Updates in Management for Patients with Cirrhosis

Feat. R. Doshi
25:53
Houston Methodist

Non-Alcoholic Fatty Liver Disease: Where Are We in 2023?

Feat. N. Gunn